blog

The Hallmarks of Aging: A Map Still Being Revised

How the hallmarks of aging organize research, why the list changed, and how to judge evidence behind claims about aging and human health.

The Hallmarks of Aging: A Map Still Being Revised
Share
PinterestFacebookLinkedInRedditTelegramX
Nov 19, 2026
Longevity Research & News

The hallmarks of aging are proposed categories of biological processes that researchers use to organize evidence about age-related changes and the loss of healthy function.

Why do the hallmarks matter for healthy aging?

  • They connect cellular changes with tissue function. An overview of the framework describes a proposed hierarchy linking damage and responses to the loss of tissue homeostasis. Homeostasis means maintaining stable internal conditions. This connects the study of aging with the question of how cells and tissues retain healthy function.
  • They place dysfunction alongside maintenance. The 2023 Cell review connected the hallmarks of aging with proposed “hallmarks of health.” These include spatial compartmentalization and maintenance of homeostasis. Adequate responses to stress also feature in that comparison, keeping the preservation of function within the research picture.
  • They help turn broad aging questions into experiments. The framework’s authors proposed criteria for testing whether a process deserves hallmark status. That gives researchers a way to move beyond observing age-related change and ask whether altering a process affects aging outcomes. For healthy-aging research, the important issue is what an experiment demonstrates about function rather than which category it mentions.

How does the framework describe aging within the body?

The hallmarks are not a single biological pathway with an established sequence of steps in humans. A useful breakdown comes instead from the framework’s proposed hierarchy. An overview of that hierarchy describes primary, antagonistic and integrative hallmarks as different parts of an account of aging.

  1. Damage enters the picture. Primary hallmarks are proposed to initiate damage. Their place in the hierarchy directs attention toward processes that may begin a chain of biological disruption. This is a proposed organizing role rather than a claim that every aging process starts at the same point.
  2. Responses can become harmful. Antagonistic hallmarks are described as processes that may become damaging when they are excessive or chronic. This introduces an important distinction: the presence of a biological response and the consequences of its sustained activity are different research questions. Context matters within the proposed hierarchy.
  3. Tissue stability is lost. Integrative hallmarks are associated with the loss of tissue homeostasis. At this level, the framework concerns the maintenance of coordinated function rather than an isolated cellular change. It gives researchers a way to discuss how multiple processes relate to the condition of a tissue.

These steps explain the logic of the hierarchy. They should not be read as a timetable in which everyone passes through a fixed succession of hallmark stages.

Why do the categories overlap?

The authors of the 2023 Cell review explicitly described the hallmarks as interconnected. The categories therefore work better as related research questions than as separate boxes.

That changes how a study should be read. A result assigned to one hallmark still needs to be considered alongside the other processes examined in the experiment. The category tells readers where the researchers placed their question; it does not replace the experiment’s methods or results.

For the same reason, a claim about “targeting a hallmark” needs more detail. Which process was altered? What else was measured? Those questions are more informative than the label alone.

What is established about the hallmarks of aging?

The clearest common ground is the framework’s organizing role in aging research. The 2023 Cell review presented interconnected categories and proposed criteria for evaluating them. It supplied a vocabulary for discussing age-related biology, while the published debate concerns how strongly particular claims of hallmark status are justified.

The framework began with nine proposed hallmarks in a 2013 Cell review. In 2023, the same five authors expanded it to twelve in Hallmarks of aging: An expanding universe. The additions were disabled macroautophagy, chronic inflammation and dysbiosis.

The twelve categories are:

  • Genomic instability
  • Telomere attrition
  • Epigenetic alterations
  • Loss of proteostasis
  • Disabled macroautophagy
  • Deregulated nutrient-sensing
  • Mitochondrial dysfunction
  • Cellular senescence
  • Stem-cell exhaustion
  • Altered intercellular communication
  • Chronic inflammation
  • Dysbiosis

The revision matters because it shows that the original authors changed their framework. The list was a scientific proposal that could be updated, not an immutable classification.

The authors also proposed three tests for hallmark status. A process should manifest with age. Experimentally accentuating it should accelerate aging. Intervening on it should offer an opportunity to decelerate, stop or reverse aging.

Those are proposed criteria, not three interchangeable kinds of evidence. Observing a change addresses a different question from deliberately worsening it. An intervention experiment asks another question again: whether changing the process improves an aging outcome.

For readers, this distinction provides a practical way to sort claims before considering their implications. First identify which test a study addresses. Then examine what the researchers actually measured.

What remains unsettled about the framework?

What would establish a cause of normal aging?

A 2026 EMBO Journal article, Seven ways not to think carefully about aging, argued that the criteria used to assign hallmark status are heterogeneous and problematic. It cautioned that a process changing with age does not by itself establish that it causes normal aging. Nor does early death after experimental disruption settle that question.

The distinction concerns what an experiment establishes. Showing that a process matters for survival is not automatically the same as showing how it contributes to ordinary aging. The critique challenges the interpretation of evidence rather than proving that every hallmark is unsupported.

A useful reading question follows: did the experiment examine normal aging or the consequences of disrupting a biological process? The answer helps define the conclusion the study can support.

How well does the evidence transfer between models?

The same EMBO Journal critique cautioned against treating cell-culture or invertebrate findings as equivalent to evidence from mammalian aging research. The framework itself also does not establish that every category has equally strong causal evidence or equally strong evidence in humans.

The practical response is to identify the experimental model before interpreting the result. A claim about aging should retain the identity of the system studied rather than becoming a general statement about people.

Next, check the outcome. An age-related association, an experimentally worsened process and an improved aging outcome answer different questions. Keeping model and outcome together is more informative than assigning a finding a general label such as “longevity evidence.”

Where should the boundaries of the list sit?

The framework’s expansion shows that its boundaries have already changed. The available reviews do not establish that the twelve categories provide a complete explanation of aging. Nor does discussion of an additional candidate establish that it has joined the original framework or gained broad acceptance.

Future proposals therefore need more than a new label. Readers can ask how the proposed category relates to existing ones and what evidence supports treating it separately. A useful revision should make the research questions clearer rather than simply lengthen the list.

How should readers use the hallmarks when judging a claim?

Treat a hallmark as a research category or hypothesis. The twelve-item review did not establish a particular consumer test or treatment. Its categories are not diagnoses, personal biological-age scores or proof that a targeted intervention will extend human life.

Start with the study’s question. Identify whether it reports an association, an experimental disruption or an intervention outcome. Then check the model and the measured result before accepting a broader claim.

When a claim introduces a biological-age number, ask what that measurement represents. AgeAmaze’s discussion of the different questions aging measurements address offers related context. For claims about personal testing, consider the separate issue of whether a result has a clear clinical interpretation.

The hallmarks earn their place by helping researchers frame better questions. Keep the map useful by asking what each experiment actually tested.

How AgeAmaze helps

Judging a hallmark study for human relevance starts with identifying what was tested; AgeAmaze explains the evidence behind that judgment. For research-minded adults facing animal findings presented as human benefits, its coverage clarifies study types and uncertainty without turning early results into treatment promises.

Read the research

Sources

  1. Hallmarks of Aging: The 12 Hallmarks and Criteria — CASRAI
  2. Seven ways not to think carefully about aging - The EMBO Journal
  3. Hallmarks of aging: An expanding universe PMID: 36599349

Stay current with research on aging biology, biomarkers, nutrition, therapeutics, peptides and longevity technology. AgeAmaze reports what the evidence shows, where uncertainty remains and which claims still need stronger data.

FacebookInstagramYouTubeXPinterest

Continue reading

Fasting-Mimicking Diet Research: Biomarkers Before Lifespan Claims
November 21, 2026
Cellular Health & Metabolism

Fasting-Mimicking Diet Research: Biomarkers Before Lifespan Claims

read article
Senolytics vs. Senomorphics: Different Actions, Different Evidence
November 21, 2026
Peptides & Emerging Therapies

Senolytics vs. Senomorphics: Different Actions, Different Evidence

read article
Yale Evidence Summary Puts Healthy Diets Ahead of Popular Supplements on DNA-Aging Measures
November 21, 2026
Nutrition & Supplements

Yale Evidence Summary Puts Healthy Diets Ahead of Popular Supplements on DNA-Aging Measures

read article
keep reading

Longevity research changes faster than the headlines

Follow AgeAmaze for careful reporting on what longevity science can show today and what still needs stronger evidence.

read the Blog
Woman reading health research at a table in natural daylight